Philip Needleman
Philip Needleman · Science & Medicine
Pharmacologist who discovered the COX-2 enzyme, leading to a new class of anti-inflammatory drugs.
1939, Brooklyn, New York, United States — 2024, St. Louis, Missouri, United States
United States
Philip Needleman is recognized among Jewish contributors to Science & Medicine — Pharmacologist who discovered the COX-2 enzyme, leading to a new class of anti-inflammatory drugs.
Needleman was an American pharmacologist and pharmaceutical executive who discovered the inducible COX-2 enzyme, opening the way to a new class of anti-inflammatory drugs including Celebrex. He chaired pharmacology at Washington University in St. Louis and led R&D at Monsanto/Searle; born into a Jewish family, he was Jewish.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biology
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Pharmacologist who discovered the COX-2 enzyme, leading to a new class of anti-inflammatory drugs.
Source: Jinfo.org — Jews in Biology
Similar Contributors
Alexander Rich
Alfred Goldberg
David Baltimore
Hans Kosterlitz
Joseph Goldstein
